Cargando…

Serum Clusterin as a Prognostic Marker of Chronic Spontaneous Urticaria

A substantial proportion of patients with chronic spontaneous urticaria (CSU) are refractory to antihistamines. However, identifying the subpopulation whose urticaria is not completely controlled by antihistamines remains difficult. The response of autologous serum skin test (ASST), a clinical test...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Ji-Hye, Lee, Hyung-Young, Ban, Ga-Young, Shin, Yoo-Seob, Park, Hae-Sim, Ye, Young-Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4902551/
https://www.ncbi.nlm.nih.gov/pubmed/27175709
http://dx.doi.org/10.1097/MD.0000000000003688
_version_ 1782437018666532864
author Kim, Ji-Hye
Lee, Hyung-Young
Ban, Ga-Young
Shin, Yoo-Seob
Park, Hae-Sim
Ye, Young-Min
author_facet Kim, Ji-Hye
Lee, Hyung-Young
Ban, Ga-Young
Shin, Yoo-Seob
Park, Hae-Sim
Ye, Young-Min
author_sort Kim, Ji-Hye
collection PubMed
description A substantial proportion of patients with chronic spontaneous urticaria (CSU) are refractory to antihistamines. However, identifying the subpopulation whose urticaria is not completely controlled by antihistamines remains difficult. The response of autologous serum skin test (ASST), a clinical test for the detection of basophil histamine-releasing activity upon autoantibodies or autoreactive stimulation, has been suggested as a potential predictor in the control of urticaria. We sought to identify proteins that were differentially expressed in the sera of patients with positive and negative ASST results and to investigate their association with urticaria control. Proteomics analysis was performed using sera from 3 CSU patients with positive ASST results compared with those showing negative ASST results. Seven upregulated and 5 downregulated proteins were identified by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry in the ASST-positive group compared with the ASST-negative group. Proteins that were differentially expressed according to the ASST results in CSU patients were classified into 6 groups: apolipoproteins, glycoproteins, modified albumin, haptoglobulin, plectin, and others. Among these, apolipoprotein J or clusterin was validated using an enzyme-linked immunosorbent assay. Clusterin levels in 69 ASST-positive patients were significantly higher than those in 69 ASST-negative patients and in 86 healthy controls (231.2 ± 44.0 vs 210.2 ± 36.1 vs 118.7 ± 71.9 μg/mL, P < 0.001). Furthermore, clusterin levels differed significantly between patients with responsive and refractory responses to antihistamine treatment within 3 months (231.0 ± 39.1 vs 205.1 ± 40.4 μg/mL, P < 0.001). ASST results and serum clusterin levels can predict 92.7% of CSU patients whose urticaria would be refractory to antihistamines. Serum clusterin can be a prognostic marker to determine the responsiveness to antihistamine treatment in patients with CSU.
format Online
Article
Text
id pubmed-4902551
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-49025512016-06-27 Serum Clusterin as a Prognostic Marker of Chronic Spontaneous Urticaria Kim, Ji-Hye Lee, Hyung-Young Ban, Ga-Young Shin, Yoo-Seob Park, Hae-Sim Ye, Young-Min Medicine (Baltimore) 3600 A substantial proportion of patients with chronic spontaneous urticaria (CSU) are refractory to antihistamines. However, identifying the subpopulation whose urticaria is not completely controlled by antihistamines remains difficult. The response of autologous serum skin test (ASST), a clinical test for the detection of basophil histamine-releasing activity upon autoantibodies or autoreactive stimulation, has been suggested as a potential predictor in the control of urticaria. We sought to identify proteins that were differentially expressed in the sera of patients with positive and negative ASST results and to investigate their association with urticaria control. Proteomics analysis was performed using sera from 3 CSU patients with positive ASST results compared with those showing negative ASST results. Seven upregulated and 5 downregulated proteins were identified by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry in the ASST-positive group compared with the ASST-negative group. Proteins that were differentially expressed according to the ASST results in CSU patients were classified into 6 groups: apolipoproteins, glycoproteins, modified albumin, haptoglobulin, plectin, and others. Among these, apolipoprotein J or clusterin was validated using an enzyme-linked immunosorbent assay. Clusterin levels in 69 ASST-positive patients were significantly higher than those in 69 ASST-negative patients and in 86 healthy controls (231.2 ± 44.0 vs 210.2 ± 36.1 vs 118.7 ± 71.9 μg/mL, P < 0.001). Furthermore, clusterin levels differed significantly between patients with responsive and refractory responses to antihistamine treatment within 3 months (231.0 ± 39.1 vs 205.1 ± 40.4 μg/mL, P < 0.001). ASST results and serum clusterin levels can predict 92.7% of CSU patients whose urticaria would be refractory to antihistamines. Serum clusterin can be a prognostic marker to determine the responsiveness to antihistamine treatment in patients with CSU. Wolters Kluwer Health 2016-05-13 /pmc/articles/PMC4902551/ /pubmed/27175709 http://dx.doi.org/10.1097/MD.0000000000003688 Text en Copyright © 2016 Wolters Kluwer Health, Inc. All rights reserved. http://creativecommons.org/licenses/by-nc/4.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC), where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially. http://creativecommons.org/licenses/by-nc/4.0
spellingShingle 3600
Kim, Ji-Hye
Lee, Hyung-Young
Ban, Ga-Young
Shin, Yoo-Seob
Park, Hae-Sim
Ye, Young-Min
Serum Clusterin as a Prognostic Marker of Chronic Spontaneous Urticaria
title Serum Clusterin as a Prognostic Marker of Chronic Spontaneous Urticaria
title_full Serum Clusterin as a Prognostic Marker of Chronic Spontaneous Urticaria
title_fullStr Serum Clusterin as a Prognostic Marker of Chronic Spontaneous Urticaria
title_full_unstemmed Serum Clusterin as a Prognostic Marker of Chronic Spontaneous Urticaria
title_short Serum Clusterin as a Prognostic Marker of Chronic Spontaneous Urticaria
title_sort serum clusterin as a prognostic marker of chronic spontaneous urticaria
topic 3600
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4902551/
https://www.ncbi.nlm.nih.gov/pubmed/27175709
http://dx.doi.org/10.1097/MD.0000000000003688
work_keys_str_mv AT kimjihye serumclusterinasaprognosticmarkerofchronicspontaneousurticaria
AT leehyungyoung serumclusterinasaprognosticmarkerofchronicspontaneousurticaria
AT bangayoung serumclusterinasaprognosticmarkerofchronicspontaneousurticaria
AT shinyooseob serumclusterinasaprognosticmarkerofchronicspontaneousurticaria
AT parkhaesim serumclusterinasaprognosticmarkerofchronicspontaneousurticaria
AT yeyoungmin serumclusterinasaprognosticmarkerofchronicspontaneousurticaria